• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, September 10, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Mason researchers Narayanan and Veneziano receive funding to build better vaccines

Bioengineer by Bioengineer
January 21, 2020
in Health
Reading Time: 1 min read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: George Mason University


George Mason University’s Aarthi Narayanan, Associate Professor, College of Science and the National Center for Biodefense and Infectious Disease, and Remi Veneziano, Assistant Professor, Volgenau School of Engineering, received $314,000 from U.S. Army Medical Research Acquisition Activity (USAMRAA) for a project researching DNA-nanoparticles and vaccine design.

This project will explore a new vaccine design that uses one-, two-, and three-dimensional structures made out of DNA molecules, commonly referred to as DNA origami, to deliver viral antigens. The benefit of this approach over traditional vaccines lies in the customizable, nanoscale organization of the DNA structures. Antigens can be placed in precise locations on the DNA scaffold, and the antigens delivered can be heterogenous/combinations. The researchers expect to find that the specificity of arrangement increases the immunogenic potential of the vaccine while ensuring safety.

The vaccine design being investigated could pave the way for a uniform approach to serious challenges, such as dengue virus and other emerging infectious agents. Following a proven approach to develop a vaccine would help it be more readily accepted by the market and decrease the time it takes to get a vaccine to patients.

###

Media Contact
George Mason University
[email protected]
703-993-7073

Tags: BiochemistryBiologyBiotechnologyGrants/FundingImmunology/Allergies/AsthmaInfectious/Emerging DiseasesMedicine/HealthVaccinesVirology
Share12Tweet8Share2ShareShareShare2

Related Posts

New ECU Study Reveals Muscle Loss in Children During Early Cancer Treatment: A Hidden Threat to Recovery

September 10, 2025

Biochar and Starch Combo Boosts Lettuce Resilience Against Antibiotic Pollution

September 10, 2025

RSV Can Severely Impact Even Healthy Children, New Research Shows

September 10, 2025

Keto Diet May Alleviate Depression Symptoms Among College Students, Study Finds

September 10, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    151 shares
    Share 60 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    52 shares
    Share 21 Tweet 13
  • First Confirmed Human Mpox Clade Ib Case China

    56 shares
    Share 22 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Critically Endangered Shark Meat Frequently Sold Under False Labels in US, Study Finds

Misconceptions Prevent Certain Cancer Patients from Accessing Hormone Therapy Benefits

New ECU Study Reveals Muscle Loss in Children During Early Cancer Treatment: A Hidden Threat to Recovery

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.